Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Madrigal Pharmaceuticals (MDGL) Tangible Book Value: 2009-2011

Historic Tangible Book Value for Madrigal Pharmaceuticals (MDGL) over the last 2 years, with Mar 2011 value amounting to $23.4 million.

  • Madrigal Pharmaceuticals' Tangible Book Value fell 49.02% to $23.4 million in Q1 2011 from the same period last year, while for Dec 2010 it was -$18.2 million, marking a year-over-year decrease of 23.81%. This contributed to the annual value of $34.8 million for FY2010, which is 23.84% up from last year.
  • Madrigal Pharmaceuticals' Tangible Book Value amounted to $23.4 million in Q1 2011, which was up 558.82% from -$5.1 million recorded in Q4 2010.
  • In the past 5 years, Madrigal Pharmaceuticals' Tangible Book Value registered a high of $45.9 million during Q1 2010, and its lowest value of -$10.4 million during Q2 2009.
  • Over the past 3 years, Madrigal Pharmaceuticals' median Tangible Book Value value was $2.6 million (recorded in 2009), while the average stood at $9.6 million.
  • In the last 5 years, Madrigal Pharmaceuticals' Tangible Book Value climbed by 28.17% in 2010 and then tumbled by 49.02% in 2011.
  • Quarterly analysis of 3 years shows Madrigal Pharmaceuticals' Tangible Book Value stood at -$7.1 million in 2009, then increased by 28.17% to -$5.1 million in 2010, then tumbled by 49.02% to $23.4 million in 2011.
  • Its last three reported values are $23.4 million in Q1 2011, -$5.1 million for Q4 2010, and $2.8 million during Q3 2010.